Find uplifting stories about heroes, innovations, and solutions
8 results for "dementia treatment"
A new biotech company just secured $175 million to develop a promising Alzheimer's treatment that could help millions of families. Korsana Biosciences is joining the fight against dementia with a fresh approach to clearing harmful brain plaques.
Scientists have identified three medicines already on pharmacy shelves that could help fight Alzheimer's, with a shingles vaccine leading the pack. The discovery could fast-track new treatments by years and save billions in development costs.
For the first time in history, new medications can actually slow the progression of Alzheimer's disease, not just mask symptoms. The breakthrough has sparked a wave of clinical trials and renewed hope among researchers who now believe they can change the course of this devastating condition.
A new study reveals how certain cancers release a protein that travels to the brain and helps clear harmful plaques linked to Alzheimer's disease. The discovery could lead to breakthrough treatments that reverse damage in patients who already have the disease.
A groundbreaking therapy just approved in Canada can slow Alzheimer's progression by 30%, keeping patients independent longer. For the first time, doctors can target the root cause of the disease instead of just managing symptoms.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
Australian researchers have developed tiny particles that can cross into the brain and destroy disease-causing proteins linked to dementia and cancer. The breakthrough technology could finally treat diseases once considered impossible to cure.
Scientists discovered that tumors release a protein that actually clears Alzheimer's plaques from the brain, explaining why cancer survivors rarely develop dementia. This breakthrough could lead to treatments that reverse existing damage instead of just slowing it down.